Literature DB >> 30846183

Elective neck dissection in oral squamous cell carcinoma: Past, present and future.

Remco de Bree1, Robert P Takes2, Jatin P Shah3, Marc Hamoir4, Luiz P Kowalski5, K Thomas Robbins6, Juan P Rodrigo7, Alvaro Sanabria8, Jesus E Medina9, Alessandra Rinaldo10, Ashok R Shaha3, Carl Silver11, Carlos Suárez12, Manuel Bernal-Sprekelsen13, Alfio Ferlito14.   

Abstract

In 1994 a decision analysis, based on the literature and utility ratings for outcome by a panel of experienced head and neck physicians, was presented which showed a threshold probability of occult metastases of 20% to recommend elective treatment of the neck. It was stated that recommendations for the management of the cN0 neck are not immutable and should be reconfigured to determine the optimal management based on different sets of underlying assumptions. Although much has changed and is published in the almost 25 years after its publication, up to date this figure is still mentioned in the context of decisions on treatment of the clinically negative (cN0) neck. Therefore, we critically reviewed the developments in diagnostics and therapy and modeling approaches in the context of decisions on treatment of the cN0 neck. However, the results of studies on treatment of the cN0 neck cannot be translated to other settings due to significant differences in relevant variables such as population, culture, diagnostic work-up, follow-up, costs, institutional preferences and other factors. Moreover, patients may have personal preferences and may weigh oncologic outcomes versus morbidity and quality of life differently. Therefore, instead of trying to establish "the" best strategy for the cN0 neck or "the" optimal cut-off point for elective neck treatment, the approach to optimize the management of the cN0 neck would be to develop and implement models and decision support systems that can serve to optimize choices depending on individual, institutional, population and other relevant variables.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Decision analysis; Elective neck dissection; Oral cancer

Mesh:

Year:  2019        PMID: 30846183     DOI: 10.1016/j.oraloncology.2019.01.016

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  17 in total

1.  [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy: a novel technique for sentinel lymph node imaging.

Authors:  Rutger Mahieu; Gerard C Krijger; F F Tessa Ververs; Remmert de Roos; Remco de Bree; Bart de Keizer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04       Impact factor: 9.236

2.  Elective Neck Dissection Versus Therapeutic Neck Dissection in Clinically Node-Negative Early Stage Oral Cancer: A Meta-analysis of Randomized Controlled Trials.

Authors:  Anshuman Kumar; Suhani Ghai; Shubhangi Mhaske; Renu Singh
Journal:  J Maxillofac Oral Surg       Date:  2022-01-06

3.  Cervical lymph node staging in head and neck tumors: bridging the gap between humans and companion animals.

Authors:  Lavinia Elena Chiti; M C Nolff; D Stefanello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-08       Impact factor: 10.057

4.  Preclinical Assessment of the Effectiveness of Magnetic Resonance Molecular Imaging of Extradomain-B Fibronectin for Detection and Characterization of Oral Cancer.

Authors:  Ryan C Hall; Nadia R Ayat; Peter L Qiao; Amita M Vaidya; Dan Ma; Anita Aminoshariae; Ivan Stojanov; Zheng-Rong Lu
Journal:  Mol Imaging Biol       Date:  2020-08-12       Impact factor: 3.488

Review 5.  Fundamental Statistical Concepts in Clinical Trials and Diagnostic Testing.

Authors:  Stephanie L Pugh; Pedro A Torres-Saavedra
Journal:  J Nucl Med       Date:  2021-02-19       Impact factor: 10.057

6.  How is neck dissection performed in Oral and Maxillofacial Surgery? Results of a representative nationwide survey among university and non-university hospitals in Germany.

Authors:  Andreas Pabst; Daniel G E Thiem; Elisabeth Goetze; Alexander K Bartella; Michael T Neuhaus; Jürgen Hoffmann; Alexander-N Zeller
Journal:  Clin Oral Investig       Date:  2021-03-29       Impact factor: 3.573

7.  Lymph node yield as a prognostic factor in clinically node negative oral cavity squamous cell carcinoma.

Authors:  Ahmad A AlTuwaijri; Mohammed A Alessa; Alanoud A Abuhaimed; Reenad H Bedaiwi; Mohammad A Almayouf; Majed M Albarrak; Saleh F Aldhahri; Khalid H Al-Qahtani
Journal:  Saudi Med J       Date:  2021-12       Impact factor: 1.422

8.  Sentinel node biopsy versus elective neck dissection in early-stage oral cancer: a systematic review.

Authors:  F M Crocetta; C Botti; C Pernice; D Murri; A Castellucci; M Menichetti; M Costantini; F Venturelli; M C Bassi; A Ghidini
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-05-30       Impact factor: 3.236

Review 9.  Novel Diagnostic Approaches for Assessment of the Clinically Negative Neck in Head and Neck Cancer Patients.

Authors:  Daphne A J J Driessen; Tim Dijkema; Willem L J Weijs; Robert P Takes; Sjoert A H Pegge; Patrik Zámecnik; Adriana C H van Engen-van Grunsven; Tom W J Scheenen; Johannes H A M Kaanders
Journal:  Front Oncol       Date:  2021-02-05       Impact factor: 6.244

10.  Research on neck dissection for oral squamous-cell carcinoma: a bibliometric analysis.

Authors:  Zhou Jiang; Chenzhou Wu; Shoushan Hu; Nailin Liao; Yingzhao Huang; Haoran Ding; Ruohan Li; Yi Li
Journal:  Int J Oral Sci       Date:  2021-04-01       Impact factor: 6.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.